Dolby Laboratories (DLB) EBITDA Margin Growth (3y) (2012 - 2026)
Dolby Laboratories (DLB) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.84 Bn | 81.56 Bn | 1.48 Bn | 256.00 |
| 2 | Relx | 65.92 Bn | 65.74 Bn | - | - |
| 3 | Copart | 31.68 Bn | 28.33 Bn | 732.88 Mn | -347.00 |
| 4 | Global Payments | 25.34 Bn | 19.93 Bn | 2.03 Bn | -1,443.00 |
| 5 | Rb Global | 16.15 Bn | 15.62 Bn | 935.50 Mn | -147.00 |
| 6 | Aramark | 15.72 Bn | 15.22 Bn | 430.34 Mn | 99.00 |
| 7 | UL Solutions | 15.16 Bn | 14.72 Bn | 417.00 Mn | 140.00 |
| 8 | Rentokil Initial | 11.92 Bn | 9.40 Bn | - | - |
| 9 | Dolby Laboratories | 6.14 Bn | 5.47 Bn | 264.68 Mn | 591.00 |
| 10 | Unifirst | 5.24 Bn | 5.07 Bn | 234.73 Mn | -216.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 591.00 |
| Mar 27, 2026 | -51.00 |
| Dec 26, 2025 | -1,016.00 |
| Sep 26, 2025 | -8.00 |
| Jun 27, 2025 | -64.00 |
| Mar 28, 2025 | 1,620.00 |
| Dec 27, 2024 | -338.00 |
| Sep 27, 2024 | 105.00 |
| Jun 28, 2024 | -682.00 |
| Mar 29, 2024 | 386.00 |
| Dec 29, 2023 | -2,127.00 |
| Sep 29, 2023 | -1,229.00 |
| Jun 30, 2023 | -849.00 |
| Mar 31, 2023 | -106.00 |
| Dec 30, 2022 | 1,145.00 |
| Sep 30, 2022 | -740.00 |
| Jul 1, 2022 | 440.00 |
| Apr 1, 2022 | -1,746.00 |
| Dec 31, 2021 | 305.00 |
| Sep 24, 2021 | 894.00 |